Brief: Carisma Announces Latest Data From Phase 1 Clinical Trial Of Ct-0508 At 8Th Annual Car-Tcr Summit
01/09/2023 13:34
Sept 1 (Reuters) - Carisma Therapeutics Inc CARM.O :
* CARISMA ANNOUNCES LATEST DATA FROM PHASE 1 CLINICAL TRIAL
OF
CT-0508 AT 8TH ANNUAL CAR-TCR SUMMIT
Source text for Eikon: ID:nPnZHj6Ra
Further company coverage: CARM.O
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary